97212 Ventures is a venture capital firm that focuses on investing in early-stage technology startups. The firm provides capital, mentorship, and strategic support to entrepreneurs aiming to drive innovation and growth in various sectors.

97212 Ventures

97212 is a seed fund exclusively focused on investing in top early stage Israeli startups committed to building category defining companies in NYC. Our check is just the beginning. We jump in, roll up our sleeves and provide hands-on tangible value from day one, so Israeli founders can truly cut time to market and build a global business from day one. 

Every company we invest in goes through a personalized process designed to hit 3 company moments - early traction, funding, and product-market-fit, while eliminating unnecessary detours. 

www.97212.vc

Congratulations to Permit.io, on their successful Series A funding round led by Scale Venture Partners, and on the launch of their groundbreaking product, Permit.io Approval Flows

This solution is set to revolutionize the way enterprises handle complex authorizations, including for AI bots and agents

We're looking forward to supporting the team, and seeing the growth of this company!

#aibusiness 
#fundinground 
#foundersjourney 
https://lnkd.in/esJF5ZCB

Big news!👏

Former Prime Minister Israeli Naftali Bennett, is joining the board of Remepy, a pioneer in the field of hybrid medications to enhance the drug effect, and one of the exciting portfolio companies at 97212 Ventures.
 
Remepy is at the forefront of developing hybrid drugs that enhance the effect of traditional medications. Their ground-breaking work has the potential to improve medical outcomes in a range of areas, including neurological diseases, cancer, autoimmune diseases, and degenerative eye diseases.
 
Congratulations to the entire Remepy team on this exciting new chapter. 

#healthcare 
#israelinnovation 
#futureofhealth 
 https://lnkd.in/gEBRNycA

Metric
Company Name	97.21K
Symbol
MSH ID	VC:97212
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	10
Website	97212.vc
LinkedIn	97212-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VC:97212

97212 Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue